上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US

上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US

ID:37128300

大小:14.29 MB

页数:38页

时间:2019-05-10

上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US_第1页
上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US_第2页
上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US_第3页
上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US_第4页
上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US_第5页
资源描述:

《上海CMC培训 Overview of Regulatory Framework and CMC Requirements in the US》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、OverviewofRegulatoryFrameworkandCMCRequirementsintheUSrichard.poska@abbott.comGlobalPharmaceuticalRegulatoryAffairsCMCRequirementsandStrategiesWorkshop28June20101PoskaCMCOverview062810PresentationGoalsExploretheroleofscienceinFDAandICHpolicyReviewFDAregulatoryCMCsubmissionreq

2、uirementsandexpectationsOutlineFDAsubmissionreviewprocessandoutcomesSummarizescience/riskbasedapproachedtoCMCsubmissionsImpactofcollaborativepartnerships:Industry,academia,andFDA2PoskaCMCOverview062810Theonewhomovesamountainbeginsbycarryingsmallstones.3PoskaCMCOverview062810U

3、SDrugRegulationMilestones1820UnitedStatesPharmacopeiaestablished1906Food&DrugsActInterstateCommerce,Adulterated,MisbrandedDrugs1937Sulfanilamide/DiethyleneGlycol1938FD&CAct(FD&CA)passedSafetydata&FactoryInspections1962ThalidomideKefauver-Harrisamendments-efficacy4PoskaCMCOver

4、view062810Frameworkfor USPharmaceuticalRegulationLaws&RegulationsReviewPublicStandardsCompliance5PoskaCMCOverview0628106PoskaCMCOverview062810USManufacturingChanges– 25YearsagoPriorapprovalperFD&CActMagnitudeofManufacturingChangeIntrinsicRiskofMolecule7PoskaCMCOverview062810T

5、heValueofGuidances8PoskaCMCOverview062810CMCRequirements-PostApprovalCategoriesforreportingchangeisgaugedonpotentialforadverseeffects:Major(PriorApproval)SubstantialpotentialModerate(CBE)ModeratepotentialMinor(AR)Minimalpotential9PoskaCMCOverview062810USManufacturingChanges-T

6、odayPriorapprovalperFDAMAAllotherchangesARperPACRegulations&GuidancesMagnitudeofManufacturingChangeIntrinsicRiskofMolecule10PoskaCMCOverview062810DesiredStatePriorapprovalperFDAMAARperPACMagnitudeofManufacturingChangeIntrinsicRiskofMoleculeHIGHRISKMolecular/ProductClinicalExp

7、erienceGMP IssuesProcessUnderstandingQbDLOWRISKControlStrategiesPAT11PoskaCMCOverview062810GeneralCharacteristicsof“Traditional”GuidancesPrescriptive(expectationsandrequirementsdefined)AllowsdefinedflexibilityHelpsbothregulatorsandindustryfocusondetailsContributestouniformint

8、erpretationandlevel“playingfield”forall12PoskaCMCOverview062810Guida

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。